Literature DB >> 25024068

Testicular cancer: a reflection on 50 years of discovery.

Nasser Hanna1, Lawrence H Einhorn2.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25024068     DOI: 10.1200/JCO.2014.56.0896

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  42 in total

1.  Impact of Teratoma on the Cumulative Incidence of Disease-Related Death in Patients With Advanced Germ Cell Tumors.

Authors:  Samuel A Funt; Sujata Patil; Darren R Feldman; Robert J Motzer; Dean F Bajorin; Joel Sheinfeld; Satish K Tickoo; Victor E Reuter; George J Bosl
Journal:  J Clin Oncol       Date:  2019-06-24       Impact factor: 44.544

2.  Recent developments in the management of germ cell tumors.

Authors:  Pavlos Msaouel; Mehmet A Bilen; Miao Zhang; Matthew Campbell; Jennifer Wang; Shi-Ming Tu
Journal:  Curr Opin Oncol       Date:  2017-05       Impact factor: 3.645

3.  The Sound of Silence: A Proxy for Platinum Toxicity.

Authors:  Jan Oldenburg; Jourik A Gietema
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

4.  Testicular Cancer as a Model for Understanding the Impact of Evolving Treatment Strategies on the Long-Term Health of Cancer Survivors.

Authors:  Lindsay M Morton
Journal:  JNCI Cancer Spectr       Date:  2020-02-27

5.  Retinal toxicity after cisplatin-based chemotherapy in patients with germ cell cancer.

Authors:  Simon Dulz; Niels H Asselborn; Klaus-Peter Dieckmann; Cord Matthies; Walter Wagner; Jens Weidmann; Christoph Seidel; Christoph Oing; Lars A Berger; Winfried Alsdorf; Blanche Mankichian; Christian Meyer; Malte W Vetterlein; Philipp Gild; Tim A Ludwig; Armin Soave; Philipp Schriefer; Andreas Becker; Sascha A Ahyai; Karin Oechsle; Carsten Bokemeyer; Lars Wagenfeld; Margit Fisch; Michael Hartmann; Felix K-H Chun; Luis A Kluth
Journal:  J Cancer Res Clin Oncol       Date:  2017-03-09       Impact factor: 4.553

6.  Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Authors:  Chunkit Fung; Howard D Sesso; Annalynn M Williams; Sarah L Kerns; Patrick Monahan; Mohammad Abu Zaid; Darren R Feldman; Robert J Hamilton; David J Vaughn; Clair J Beard; Christian K Kollmannsberger; Ryan Cook; Sandra Althouse; Shirin Ardeshir-Rouhani-Fard; Steve E Lipshultz; Lawrence H Einhorn; Sophie D Fossa; Lois B Travis
Journal:  J Clin Oncol       Date:  2017-02-27       Impact factor: 44.544

7.  Long-Term Cognitive Functioning in Testicular Germ-Cell Tumor Survivors.

Authors:  Michal Chovanec; Lucia Vasilkova; Lucia Setteyova; Jana Obertova; Patrik Palacka; Katarina Rejlekova; Zuzana Sycova-Mila; Katarina Kalavska; Daniela Svetlovska; Silvia Cingelova; Beata Mladosievicova; Jozef Mardiak; Michal Mego
Journal:  Oncologist       Date:  2018-01-19

8.  The Evolving Management of Patients With Clinical Stage I Seminoma.

Authors:  Richard S Matulewicz; Daniel T Oberlin; Joel Sheinfeld; Joshua J Meeks
Journal:  Urology       Date:  2016-08-12       Impact factor: 2.649

9.  Clinical trial spots for cancer patients by tumour type: The cancer trials portfolio at clinicaltrials.gov.

Authors:  Vinay Prasad; Jeffery A Goldstein
Journal:  Eur J Cancer       Date:  2015-08-25       Impact factor: 9.162

Review 10.  Management of stage I testicular germ cell tumours.

Authors:  Michal Chovanec; Nasser Hanna; K Clint Cary; Lawrence Einhorn; Costantine Albany
Journal:  Nat Rev Urol       Date:  2016-09-13       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.